首页> 外国专利> Pharmaceutical composition for treatment of cancers or inhibition of metastasis comprising photothermal nanoparticle conjugated immune checkpoint inhibitor and adjuvant

Pharmaceutical composition for treatment of cancers or inhibition of metastasis comprising photothermal nanoparticle conjugated immune checkpoint inhibitor and adjuvant

机译:包含光热纳米粒子结合的免疫检查点抑制剂和佐剂的用于治疗癌症或抑制转移的药物组合物

摘要

The present invention relates to a pharmaceutical composition for the treatment of cancer or the inhibition of cancer metastasis, comprising as an active ingredient a photothermal nanoparticle and an immunomodulator (adjuvant) bound to the surface of an immune checkpoint inhibitor (immune checkpoint inhibitor), the composition of the present invention It accumulates specifically on tumor cells, has a remarkable effect on photothermal treatment by near-infrared irradiation, promotes differentiation of dendritic cells, and acts as an endogenous vaccine for tumor cells, immune checkpoint inhibitors and immunomodulators killed after photothermal treatment. Therefore, it has a therapeutic effect on not only primary tumors but also metastatic tumors.
机译:本发明涉及用于治疗癌症或抑制癌症转移的药物组合物,其包含作为活性成分的光热纳米颗粒和结合至免疫检查点抑制剂(免疫检查点抑制剂)表面的免疫调节剂(佐剂),本发明的组合物特别地在肿瘤细胞上蓄积,对近红外光照射的光热处理有显着的作用,促进树突状细胞的分化,并用作光热处理后被杀死的肿瘤细胞,免疫检查点抑制剂和免疫调节剂的内源性疫苗。 。因此,它不仅对原发性肿瘤而且对转移性肿瘤都有治疗作用。

著录项

  • 公开/公告号KR102135840B1

    专利类型

  • 公开/公告日2020-07-20

    原文格式PDF

  • 申请/专利权人 서울대학교산학협력단;

    申请/专利号KR20180082962

  • 发明设计人 오유경;심가용;르비엣쿠옥;

    申请日2018-07-17

  • 分类号A61K41;A61K31/4745;A61K39/395;A61P35;

  • 国家 KR

  • 入库时间 2022-08-21 11:04:12

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号